Amidst rising global trade tensions and economic uncertainty, Singapore seeks to expedite negotiations with the United States for critical concessions
About the Author
Warisha Rashid covers AI stocks and crypto markets for TECHi. Recent work explains what changed when Worldcoin cut its WLD token unlock, how AMD's rack-scale Helios design fits an asset-light strategy, and how Nvidia, Alphabet, Palantir, AMD and Broadcom compare as AI businesses.
Amidst rising global trade tensions and economic uncertainty, Singapore seeks to expedite negotiations with the United States for critical concessions about pharmaceutical tariffs while simultaneously ensuring continued access to advanced AI chips. The broad context of these negotiations matters, considering the projected slowdown in the city-state's trade-dependent economy, coupled with the lowered GDP growth forecast for 2025. These negotiations reflect Singapore's balancing act at the crossroads of technology, trade, and geopolitics, which will determine the outcome of the nation's future economic reality.
Exports of pharmaceuticals to the US make up over 10% of Singapore's exports to the United States, thus making it an important part of Singapore's economic relationship with its biggest trading partner. The United States, though, has threatened to impose tariffs on these exports, adding issues to Singapore's trade prospects. Earlier on, US President Donald Trump hinted at imposing such tariffs, and even when talks are underway, Singapore Trade and Deputy Prime Minister Gan Kim Yong's remarks make it clear that concessions sought must be made in the negotiations. Singapore's pharmaceutical sector is already dealing with disrupted supply lines and increased expenses from other countries, leading to tariffs further straining the industry as it is going through the supply-side/inflationary stagflation that brings even worse outcomes. Combined with these factors, Singapore is also experiencing an economic slowdown as GDP growth is lowered to a 0%-2% guesstimate for the upcoming year after a year-on-quarter dip, feeding the cost-of-living crisis while the headline ruling party is looking to get their votes up before May 2025.
Alongside the medicine topic, negotiating access to AI chips has become a primary battleground. Ultra-modern AI chips vital to Singapore’s burgeoning technology industry, especially in AI and machine learning, face highly restrictive export controls from the United States. Access to these chips is essential for Singapore’s continued innovation and competitiveness as a hub in the global semiconductor supply chain. Deputy Prime Minister Gan had a call with US Secretary of Commerce Howard Lutnick. During this call, Gan brought up the issue of export controls while highlighting Singapore’s compliance with US orders, as well as Singapore’s active role in preventing the misuse of AI technologies. In response to these points, Lutnick agreed but added that export controls have broader issues, hinting that there may be a shift in the world's semiconductor ecosystem. These conversations illustrate the changing geostrategic struggles related to the trade of sophisticated technologies in the context of intensifying competition, including China's eyeing of independent AI chip production.
With regard to tariffs and export controls, bilateral trade ties with the US remain crucial to Singapore. Singapore’s trade needs are paramount, considering the world’s economy and the tariff and regulatory battle zones. The trade relationship with the United States is not risk-free either. Singapore faces real economic costs if it fails to resolve these targeted trade challenges. Focused on its economic mission and deepening its portfolio as a global trading and technology pivot, Singapore is still pursuing autonomy ahead of forthcoming elections alongside an economic slowdown. How the tiny city-state navigates these negotiations and secures a satisfactory resolution on pharmaceutical exports and access to AI chips will shape confidence amid global volatility.
About the Author
Warisha Rashid covers AI stocks and crypto markets for TECHi. Recent work explains what changed when Worldcoin cut its WLD token unlock, how AMD's rack-scale Helios design fits an asset-light strategy, and how Nvidia, Alphabet, Palantir, AMD and Broadcom compare as AI businesses.
Keep reading
Comments